Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More informationNew MHRA CEO puts safety, accelerated access and innovation at the centre of agency’s refreshed strategic direction.
Since, April 2024, the MHRA has been using Lorenz DocuBridge for eCTD management in product license submissions. This change is part of the modernisation of the MHRA’s Legacy Systems and is one of the initial tools launched in the RegulatoryConnect programme.
New Post-Market Surveillance (PMS) regulations have taken effect across Great Britain, requiring medical device manufacturers to proactively monitor the safety and performance of their products once on the market.
The newsletter for patients, consumers and healthcare professionals
Millions will take part in clinical trials under the 10 Year Health Plan which will speed up clinical research.
Comments Published
The RQA GPvP Committee have collated relevant pharmacovigilance news and will share quarterly.
Updated and published guidance on decentralised manufacture released.
Information to help you understand and prepare for the main regulatory changes that The Human Medicines (Amendment) Modular Manufacture and Point of Care regulations 2025 will introduce for the manufacture of medicines at - or close to - the point of patient care.
Documentation changed to support changes to Manufacturer Incident Reports (MIRs) and Field Safety Corrective Action Reports (FSCAs)